# Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial

> **NCT00667043** · PHASE4 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 60 (actual)

## Conditions studied

- Hypothermia

## Interventions

- **DRUG:** remifentanil and propofol
- **DRUG:** fentanyl and midazolam

## Key facts

- **NCT ID:** NCT00667043
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-05
- **Final completion:** 2010-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667043, "Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00667043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*